Back
State Street SPDR S&P Biotech ETF 10K Form
Buy
75
XBI
State Street SPDR S&P Biotech ETF
Last Price:
$123.29
Seasonality Move:
4.35%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XBI News And Ratings
See the #1 stock for the next 7 days that we like better than XBI
XBI Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
State Street SPDR S&P Biotech ETF Earnings Forecast
Key State Street SPDR S&P Biotech ETF Financial Ratios
State Street SPDR S&P Biotech ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSEARCA |
|---|---|
| Current Symbol: | XBI |
| CUSIP: | 78464A |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XBI Technical Analysis vs Fundamental Analysis
Buy
75
State Street SPDR S&P Biotech ETF (XBI)
is a Buy
Is State Street SPDR S&P Biotech ETF a Buy or a Sell?
-
State Street SPDR S&P Biotech ETF stock is rated a BuyThe current State Street SPDR S&P Biotech ETF [XBI] share price is $123.25. The Score for XBI is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.